Sequoia Financial Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $521K | Buy |
3,432
+1,677
| +96% | +$254K | ﹤0.01% | 967 |
|
|
2025
Q1 | $264K | Sell |
1,755
-207
| -11% | -$31.2K | ﹤0.01% | 1109 |
|
|
2024
Q4 | $362K | Sell |
1,962
-7,569
| -79% | -$1.4M | ﹤0.01% | 931 |
|
|
2024
Q3 | $1.88M | Sell |
9,531
-4,685
| -33% | -$923K | 0.02% | 390 |
|
|
2024
Q2 | $2.94M | Buy |
14,216
+665
| +5% | +$137K | 0.04% | 259 |
|
|
2024
Q1 | $3.67M | Sell |
13,551
-557
| -4% | -$151K | 0.05% | 232 |
|
|
2023
Q4 | $3.34M | Buy |
14,108
+13,068
| +1,257% | +$3.09M | 0.04% | 259 |
|
|
2023
Q3 | $204K | Buy |
1,040
+5
| +0.5% | +$980 | ﹤0.01% | 858 |
|
|
2023
Q2 | $218K | Sell |
1,035
-37
| -3% | -$7.78K | ﹤0.01% | 833 |
|
|
2023
Q1 | $216K | Buy |
1,072
+26
| +2% | +$5.25K | ﹤0.01% | 736 |
|
|
2022
Q4 | $228K | Buy |
+1,046
| New | +$228K | 0.01% | 685 |
|